Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
Principal Investigator
Theodore Hong, MD
Status
Terminated
Date Opened To Accrual
September 29 2014
Date Closed to Accrual
July 02 2018
Date of Study Termination
July 02 2018
Disease Site
Gastrointestinal [GI]
Liver
Phase
III
Developmental Therapeutics
No
Primary Objective
To evaluate the addition of liver-directed radiation therapy to chemotherapy with respect to overall survival (OS) for patients with unresectable, localized intrahepatic cholangiocarcinoma
Patient Population
Pathologically (histologically or cytologically) proven diagnosis of IHC without distant extrahepatic metastasis
Target Accrual
146
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.